this post was submitted on 23 Jun 2023
19 points (100.0% liked)

Science

13025 readers
16 users here now

Studies, research findings, and interesting tidbits from the ever-expanding scientific world.

Subcommunities on Beehaw:


Be sure to also check out these other Fediverse science communities:


This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] wjs018 2 points 1 year ago

So, Sarepta has multiple approved therapies that haven't reached positive clinical endpoints? How many times can the agency/drugmaker justify accelerated approval based on an unmet clinical need?

Imo, this just adds to the growing criticism of the agency's growing use of accelerated approvals without holding pharma companies to their post-approval obligations.